Gravity Analytica

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

AVDL 01.03.2025

SERA-AI Powered Highlights

Date of Upcoming Event:2025-01-08

Name of Upcoming Event:Corporate Update and Financial Results Call

Full Press Release SEC Filings Our AVDL Tweets

About Gravity Analytica

Recent Filings

PDF Version

DUBLIN,Jan. 03, 2025(GLOBE NEWSWIRE) --Avadel Pharmaceuticals plc(Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 4:30 p.m. ET on Wednesday, January 8, 2025, to provide a corporate update and discuss the Company's preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024.

A live audio webcast of the call can be accessed by visiting the investor relations section of the Company’s website,www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event.

Participants may register for the conference callhereand are advised to do so at least 10 minutes prior to joining the call.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZTM, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years and older with narcolepsy. For more information, please visitwww.avadel.com.

Investor Contact:

Austin MurtaghPrecision AQAustin.Murtagh@precisionaq.com (212) 698-8696

Media Contact:

Lesley StanleyReal Chemistrylestanley@realchemistry.com (609) 273-3162

Source: Avadel Pharmaceuticals plc

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com